Melting point	310-312 ºC (acetic acid )**
Density	1.468±0.06 g/cm3 (20 º

没有数据	没有数据

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

Oncogenic role of microRNA-155 in mycosis fungoides: an in vitro and xenograft mouse model study.L Moyal et al.The British journal of dermatology, 177(3), 791-800 (2017-03-04) Cross Interaction between M2 Muscarinic Receptor and Notch1/EGFR Pathway in Human Glioblastoma Cancer Stem Cells: Effects on Cell Cycle Progression and Survival.Ilaria Cristofaro et al.Cells, 9(3) (2020-03-19) HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.Clélia Dental et al.Journal of immunology (Baltimore, Md. : 1950), 198(3), 1229-1241 (2016-12-21) The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes.Ibrahim F Benter et al.Journal of drug targeting, 23(6), 506-518 (2015-06-27) PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors.Minghui Liu et al.Oncotarget, 7(51), 84951-84964 (2016-11-09) Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.Kristin M Müller et al.BMC cancer, 11, 421-421 (2011-10-04) Effect of Selective Serotonin (5-HT)2B Receptor Agonist BW723C86 on Epidermal Growth Factor/Transforming Growth Factor-α Receptor Tyrosine Kinase and Ribosomal p70 S6 Kinase Activities in Primary Cultures of Adult Rat Hepatocytes.Kota Naito et al.Biological & pharmaceutical bulletin, 42(4), 631-637 (2019-02-05) EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.Florian Sevelda et al.Journal of experimental & clinical cancer research : CR, 34, 134-134 (2015-11-04)

Remarks